Granulocyte Macrophage Colony-Stimulating Factor in 66 Patients with Myeloid or Lymphoid Neoplasms and Recipients of Hematopoietic Stem Cell Transplantation with Invasive Fungal Disease

Human Natural Killer Cells Exhibit Direct Activity Against Aspergillus fumigatus Hyphae, But Not Against Resting Conidia

(2010) Stanislaw Schmidt et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of Liposomal Amphotericin B Combined with Gamma Interferon or Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Systemic Zygomycosis in Mice

(2009) M. M. Rodriguez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-Induced neutropenia

(2009) Mark L. Heaney et al.   CANCER

Inhaled therapeutics for prevention and treatment of pneumonia

(2009) Amar Safdar et al.   Expert Opinion On Drug Safety

Host immune response againstScedosporiumspecies

(2009) Emmanuel Roilides et al.   MEDICAL MYCOLOGY

Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection

(2008) R. F. Chemaly et al.   HAEMATOLOGICA

Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis

(2008) A. Bandera et al.   INFECTION

Progressive fusariosis: Unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection

(2008) Roshan Lewis et al.   LEUKEMIA & LYMPHOMA